Microcystic Changes in the Retinal Internal Nuclear Layer Associated with Optic Atrophy: A Prospective Study

Purpose. This study aimed at assessing the prevalence of pathologies presenting retinal inner nuclear layer (RINL) microcystic perimacular changes associated with optic nerve atrophy (OA). The charts of patients presenting a significant defect of the Retinal Nerve Fiber Layer (RNFL) were included prospectively in this study. Patients were classified according to the etiology of the RNFL defect. Two hundred and one eyes of 138 patients were enrolled in this analysis. Retinal images obtained showed the typical hyporeflective perifoveal crescent-shaped lesion composed of small round hyporeflective microcysts confined to the RINL in 35.3% of the eyes. Those findings were found in 75% of eyes presenting hereditary OA, 50% of eyes presenting ischemic optic neuritis, 50% of eyes with drusen of the optic nerve (ON), 44.4% of eyes presenting a compressive OA, 32% of eyes presenting inflammatory optic neuropathy from multiple sclerosis, 18.5% of eyes presenting OA from undetermined origin, and 17.6% of eyes having primary open-angle glaucoma. This study demonstrates that microcystic changes in RINL are not specific to a disease but are found in OA of various etiologies. Moreover, their incidence was found to be dependent upon the cause of OA, with the highest incidence occurring in genetic OA.

[1]  J. Sahel,et al.  RETINAL INNER NUCLEAR LAYER MICROCYSTIC CHANGES IN OPTIC NERVE ATROPHY: A Novel Spectral-Domain OCT Finding , 2013, Retina.

[2]  A. Green,et al.  Microcystic inner nuclear layer abnormalities and neuromyelitis optica. , 2013, JAMA neurology.

[3]  C. Crainiceanu,et al.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study , 2012, The Lancet Neurology.

[4]  José-Alain Sahel,et al.  En Face OCT Imaging for the Diagnosis of Outer Retinal Tubulations in Age-Related Macular Degeneration , 2012, Journal of ophthalmology.

[5]  A. Green,et al.  Microcystic macular oedema in multiple sclerosis is associated with disease severity. , 2012, Brain : a journal of neurology.

[6]  I. Allen,et al.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. , 2010, Brain : a journal of neurology.

[7]  R. Casson Possible role of excitotoxicity in the pathogenesis of glaucoma , 2006, Clinical & experimental ophthalmology.

[8]  H. Kalbacher,et al.  OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina. , 2004, Investigative ophthalmology & visual science.

[9]  L. Zangwill,et al.  Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. , 2004, Investigative ophthalmology & visual science.

[10]  W. Hare,et al.  Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. , 2001, Survey of ophthalmology.

[11]  F. Fitzke,et al.  Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. , 1998, Archives of ophthalmology.

[12]  V. Smith,et al.  A clinicopathologic study of autosomal dominant optic atrophy. , 1979, American journal of ophthalmology.

[13]  Cathy Frey,et al.  Investigative Ophthalmology and Visual Science , 2010 .

[14]  S. Lipton,et al.  Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. , 2008, Progress in brain research.

[15]  W. Hare,et al.  Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. , 2004, Investigative ophthalmology & visual science.